Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00309712 · ClinicalTrials.gov registry record · NA
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
A NA study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT00309712: Completed NA study, sponsored by Intermountain Health Care.
NCT00309712 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00309712, a NA study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The primary study hypothesis of this study is to determine whether there is a greater percentage of patients achieving a triglyceride level of \<200 mg/dL with the combination of simvastatin 20 mg and fenofibrate 160mg than with either simvastatin 20 mg monotherapy or fenofibrate 160mg monotherapy.
Interventions
- DRUG fenofibrate 160 mg and placebo
- DRUG simvastatin 20 mg and placebo
- DRUG fenofibrate 160 mg and simvastatin 20 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-09 |
| Phase | NA |
What the finished NCT00309712 record still lists
NCT00309712 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which fenofibrate 160 mg and placebo is the first listed.
NCT00309712 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00309712 about?
NCT00309712 is a clinical study titled "Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study". The primary study hypothesis of this study is to determine whether there is a greater percentage of patients achieving a triglyceride level of \<200 mg/dL with the combination of simvastatin 20 mg and fenofibrate 160mg than with either simvastatin 20 mg monotherapy or fenofibrate 160mg monotherapy.
What is the current status of trial NCT00309712?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2002-08. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00309712?
The interventions under investigation include: fenofibrate 160 mg and placebo (DRUG), simvastatin 20 mg and placebo (DRUG), fenofibrate 160 mg and simvastatin 20 mg (DRUG).
Who is sponsoring clinical trial NCT00309712?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00309712's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia